Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Drop of blood could spot deadly poison in minutes

NCT ID NCT06881641

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new bedside test that uses a single drop of blood to diagnose methanol poisoning, a major problem in low-income countries. The test measures formate, a toxic byproduct of methanol, and could give results in minutes instead of hours. The trial will first check how accurate the test is compared to standard lab tests, then see if using it in hospitals helps speed up treatment and save lives.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
point-of-care formate assay (bedside blood test)
What this could lead to
If successful, this test could allow doctors to diagnose methanol poisoning quickly and cheaply at the bedside, potentially saving many lives during outbreaks.
What could go wrong
This is an early-stage study testing the test's accuracy and feasibility. The test may not be as accurate as lab tests, and the second part is small, so results may not apply everywhere.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 6,120 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2025

Expected to finish

Feb 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population will include patients presenting to large referral hospitals in 2 countries (Bangladesh, India) with suspicion of methanol poisoning or unexplained metabolic acidosis.

Ages

16 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: • Patients presenting with suspected methanol poisoning or metabolic acidosis of unknown cause, including: * Children aged 16-17 years, who are willing to provide assent. * Parents/Guardians of children who are able and willing to provide consent. * Adults (aged 18 years with no upper age limit) who are willing to provide informed consent. * Participants who lack capacity to consent for themselves but who have a relative who is willing and able to provide informed consent on behalf of the participant. Suspected methanol poisoning will be based on clinician judgement using the following typical indicators of possible methanol ingestion: 1. History of: * Intake of illegal/bootleg/spurious alcohol, and/or * Other patients admitted with confirmed/suspected methanol poisoning and/or * Time from intake to symptoms \>6-12 h 2. Symptoms/clinical findings * Coma, and/or * Hyperventilation (respiratory rate \[RR\] \>20/min) and/or dyspnea, and/or * Visual disturbances (blurred vision, blindness), and/or * Gastrointestinal symptoms (vomiting, abdominal pain), and/or * Chest pain, and/or * Severe/unusual 'hang-over': Feeling very sick the following day, and/or * Pseudopapillitis Metabolic acidosis of unknown origin will be based on the following features: * Metabolic acidosis of unknown origin = origin not identified. The acidosis is not of unknown origin if the metabolic acidosis can be explained by another cause eg. lactic acidosis (e.g. where base deficit \[BD\] = 15 mM \[i.e., base excess (BE) = -15 mM\] and lactate is 12-15mM). * An initial ABG shall be drawn. If the BD is \>15mM (BE\<-15mM), the patient shall be included (as long as "unknown origin" - see above). If the patient has a BD between 5-15, the acidosis is only moderate, and there is time to do the "fluid trial" (see below). If the acidosis improves within 1-2 hours after the fluid trial, the acidosis is unlikely to be because of methanol and the patient should not be included. If the acidosis does not improve, the patient should be included. Exclusion Criteria: * • Children aged 16-17 years, who are unwilling to provide assent. * Parents/Guardians of children who are unable or unwilling to provide consent. * Adults (aged 18 years with no upper age limit) who are unwilling to provide informed consent. * Participants who lack capacity to consent for themselves and who do not have a relative who is willing and able to provide informed consent on behalf of the participant (i.e. unaccompanied unconscious patients and others) * Individuals previously recruited to the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Metabolic acidosis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    6 sites in 2 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Chittagong Medical College Hospital

    RECRUITING

    Chittagong, Bangladesh

  • Dhaka Medical College Hospital

    RECRUITING

    Dhaka, 1205, Bangladesh

  • Mag Osmania Medical College Hospital Sylhet

    RECRUITING

    Sylhet, Bangladesh

  • PGIEMR

    NOT_YET_RECRUITING

    Chandigarh, India

  • Rahshahi medical college hospital

    RECRUITING

    Rajshahi, Rajshahi Division, 6000, Bangladesh

  • SZMCH

    RECRUITING

    Bogra, Bogura, 5800, Bangladesh

More trials for these conditions

Other studies related to the condition(s) this trial covers.